Implicit in the idea of medical audit are two notions: the quantifying of medical practice in terms of treatment, procedures, outcomes, and complications; and the use of these data to exact some form of accountability. Therefore some sort of objective monitoring, or quality control, of practices or procedures is needed so that periods of suboptimal performance in relation to an agreed standard can be recognised and, ideally, remedied.
Objective monitoring or quality control has been used for surveillance: methods have been developed to detect increases in rare events, such as birth malformations and to detect minimal epidemics.' A review of the concepts and definitions of quality control procedures that are commonly used in clinical chemistry have also been presented.2 The use of the cumulative sum (cusum) has been suggested for both surveillance and quality control. Its use for examining sequential measures or for looking for changes over time has recently been described.3 It has also been used for plotting temperature charts for assessing antimicrobial treatment in neutropenic patients. 4 Because the cusum shows changes over time it can be used by individual practitioners to monitor their own performance as a form of quality control to give proof of ongoing competence in a particular skill. It can also be used to show progress in mastering a new technique. One advantage of this sort of self assessment is that an acceptable level of attainment must be defined so that how well it is met can be quantified. It has been suggested, for instance, that the completion rate for colonoscopic examination should be above 90%. 5 The cusum has been described as a useful graphical tool for discerning trends. where Xi = 0 for a success and Xi= 1 for a failure. Xo is a reference or target value. The cusum is interpreted by looking at its gradient or slope. For a series of observations which meet the specified criterion the cusum should be relatively level. If the reference value is specified in terms of an acceptable failure rate, for instance, the cusum will increase and consequently will have a positive slope when the failure rate is higher than the target value, and it will decrease when the failure rate is lower than that specified. This means that if the failure rate were specified as 10%, for instance, 0 9 would be added to the cusum for a failure and -0-1 for a success. In a series of examinations consisting of a success followed by a failure and four successes the cusum would take the values -0 1, 0-8, 0 7, 0 6, and 0 5. The first example concerns the outcome of the 361 examinations done by the experienced colonoscopist; the cusum is shown in figure 1. As it had been 15- suggested that an acceptable failure rate for colonoscopies should be less than 10%5 this value was used as the reference or target value for the cusum. As a failure rate of 20% was considered unacceptable boundary lines were constructed to identify series of observations in which the failure rate increased to 20% or more. It was found that, with a small amount of rounding, a boundary line 2 Figure 3 shows the learning process. It seems that only 30 cases were needed for the operator to become proficient.
In another long series of selected endoscopic retrograde cholangiopancreatography examinations a completion rate of 95% was reported.' This standard is also shown in figure 3 . Because the cusum continued to rise it must be concluded that a 95% success rate was not reached in this series. A success rate as high as 95% may be an unrealistic goal for a series of unselected examinations.
Discussion
The advantage of a quality control procedure such as this is that after each observation it is possible to make one of two decisions: to accept that the level of technical performance is satisfactory or to conclude that some real change has occurred, a decision made if the cusum meets one of the boundary lines from below. The first example shows that the cusum can be used to show that a practitioner can achieve and maintain an acceptable level of success in carrying out a particular procedure. Figure 1 gives a good overview of the performance of the experienced colonoscopist and identifies several periods that were characterised by long runs of successes.
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In both the second and third examples the examiners were beginners, and it is clear that their initial performances did not meet the specified standard. The cusum does, however, suggest that after about 80 examinations the performance of the colonoscopist reached an acceptable level, and it gives a good picture of his experience from novice to skilled examiner. A more complete audit would describe the findings of each examination. 10 The third example shows a shorter learning phase before a 90% success rate was achieved. Again, the cusum indicates how the proportion of successes has changed over time. These examples highlight the advantages of the cusum: its use allows individuals to prove how proficient they have become by quantifying how well their success rate meets an agreed standard. Instead of consisting of an arbitrary number of examinations, training can be continued until an acceptable level of attainment is reached, and supervision and guidance can be tailored to meet individual needs.
Maintaining levels of technical skill is not enough. The findings and the outcome of examinations should also be recorded so that patterns of results can be examined and comparisons made with other examiners, possibly in other centres, and over time. Quality control and objective and quantified recording of the findings meet the recommended criteria for medical audit."
We recommend that this simple cusum technique be considered as a means of monitoring performance, both in the learning phase and in the maintenance of standards. Its potential application to other clincial procedures such as chorionic villus sampling, fine needle aspiration of the pancreas under ultrasound, intubation ofthe newborn, radial artery catheterisation in neonatology, central vein cannulation of adults, or for surgical procedures either for quality control or to illustrate the learning process should be considered.
While meeting the specified success rate for each procedure is a personal issue, the setting of explicit criteria makes comparisons among different operators and different units much more straightforward and provides a quantitative measure for audit. The cusum can also be used when the variable of interest is continuous; again, an agreed target value must be made explicit.
Appendix
This appendix gives the formulas, provided by Davies,6 on which the boundary lines were based. s=Q/(P+Q) (1) ho=b/(P+Q) (2) hl=a/(P+Q) (3) where P= ln(p1/po), Q= ln(l-po)/(l-p1), a= ln(l-,B)/a, and b= ln(I-6)/P.
po corresponds to the failure rate under the null hypothesis.
Pi corresponds to the failure rate under the alternative hypothesis. a is the risk of accepting a bad batch of observations.
1B is the risk of rejecting a good batch of observations.
As s was to be used as the target value for the cusum s=0 1, the failure rate considered to be unacceptable was 0-2. The value of po can be found from (1) using trial and error. In this case po=0-04. Breast cancer is Britain's most common malignancy in women, estimated to affect one in 12 of the female population. About 80% of women present with apparently localised disease which is surgically resectable: so called early breast cancer. Nevertheless, about half relapse despite intended curative treatment. Controversy about the treatment of early breast cancer has existed for at least a century and continues. Two questions have predominated. Firstly, is mastectomy necessary or can the affected breast safely be preserved? Secondly, can adjuvant systemic therapy eliminate micrometastatic disease present, but not identifiable, at diagnosis, and ifso how should patients best be selected for such treatment? The available evidence on these issues is considered and a reasonable approach to present good practice is described.
Definition of early breast cancer
The term early breast cancer describes disease which, at presentation and after initial assessment, is apparently confined to the breast and deemed to be technically resectable; axillary lymph nodes may be palpable. The cancer is operable ifclinical examination excludes extension of the primary tumour or axillary node metastases to either the skin or the chest wall and confirms that there is no supraclavicular lymphadenopathy. In other words, signs oflocally advanced disease are absent. Ancillary investigations, aiming at identifying potential distant metastases, normally include haematological and biochemical tests and chest radiography. If these produce normal results many doctors consider further investigation unnecessary. However, isotopic bone scanning to screen for skeletal metastases is often routinely performed, but the low positive predictive value has called into question the cost effectiveness of this investigation. ' The term early to describe operable breast cancer is often a misnomer as the low resolution of staging tests means that occult metastatic disease is not identified in many patients. The risk of distant metastatic disease is particularly high when axillary lymph nodes are BMJ VOLUME 304 23 MAY 1992
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